176 related articles for article (PubMed ID: 2316066)
1. Effects of different doses of alkaline citrate on urine composition and crystallization of calcium oxalate.
Berg C; Larsson L; Tiselius HG
Urol Res; 1990; 18(1):13-6. PubMed ID: 2316066
[TBL] [Abstract][Full Text] [Related]
2. Alkaline citrate in prevention of recurrent calcium oxalate stones.
Berg C
Scand J Urol Nephrol Suppl; 1990; 130():1-83. PubMed ID: 2291093
[TBL] [Abstract][Full Text] [Related]
3. The effects of a single evening dose of alkaline citrate on urine composition and calcium stone formation.
Berg C; Larsson L; Tiselius HG
J Urol; 1992 Sep; 148(3 Pt 2):979-85. PubMed ID: 1507355
[TBL] [Abstract][Full Text] [Related]
4. Effects of citrate on the different phases of calcium oxalate crystallization.
Tiselius HG; Berg C; Fornander AM; Nilsson MA
Scanning Microsc; 1993 Mar; 7(1):381-9; discussion 389-90. PubMed ID: 8316807
[TBL] [Abstract][Full Text] [Related]
5. Magnesium, citrate, magnesium citrate and magnesium-alkali citrate as modulators of calcium oxalate crystallization in urine: observations in patients with recurrent idiopathic calcium urolithiasis.
Schwille PO; Schmiedl A; Herrmann U; Fan J; Gottlieb D; Manoharan M; Wipplinger J
Urol Res; 1999 Apr; 27(2):117-26. PubMed ID: 10424393
[TBL] [Abstract][Full Text] [Related]
6. How are urine composition and stone disease affected by therapeutic measures at an outpatient stone clinic?
Tiselius HG; Sandvall K
Eur Urol; 1990; 17(3):206-12. PubMed ID: 2351189
[TBL] [Abstract][Full Text] [Related]
7. Is citrate an inhibitor of calcium oxalate crystal growth in high concentrations of urine?
Bek-Jensen H; Fornander AM; Nilsson MA; Tiselius HG
Urol Res; 1996; 24(2):67-71. PubMed ID: 8740974
[TBL] [Abstract][Full Text] [Related]
8. Urinary saturation and risk factors for calcium oxalate stone disease based on spot and 24-hour urine specimens.
Ogawa Y; Yonou H; Hokama S; Oda M; Morozumi M; Sugaya K
Front Biosci; 2003 Sep; 8():a167-76. PubMed ID: 12957883
[TBL] [Abstract][Full Text] [Related]
9. Calcium oxalate crystallization in undiluted postprandial urine of healthy male volunteers as influenced by citrate.
Fan J; Schwille PO; Schmiedl A; Fink E; Manoharan M
Arzneimittelforschung; 2001 Oct; 51(10):848-57. PubMed ID: 11715639
[TBL] [Abstract][Full Text] [Related]
10. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A
Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942
[TBL] [Abstract][Full Text] [Related]
11. Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis.
Kato Y; Yamaguchi S; Yachiku S; Nakazono S; Hori J; Wada N; Hou K
Urology; 2004 Jan; 63(1):7-11; discussion 11-2. PubMed ID: 14751336
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of stone formers treated with a low dose of sodium potassium citrate.
Jendle-Bengten C; Tiselius HG
Scand J Urol Nephrol; 2000 Feb; 34(1):36-41. PubMed ID: 10757268
[TBL] [Abstract][Full Text] [Related]
13. The composition of four-hour urine samples from patients with calcium oxalate stone disease.
Berg C; Larsson L; Tiselius HG
Br J Urol; 1987 Oct; 60(4):301-6. PubMed ID: 3690199
[TBL] [Abstract][Full Text] [Related]
14. Calcium citrate: reduced propensity for the crystallization of calcium oxalate in urine resulting from induced hypercalciuria of calcium supplementation.
Harvey JA; Zobitz MM; Pak CY
J Clin Endocrinol Metab; 1985 Dec; 61(6):1223-5. PubMed ID: 4055988
[TBL] [Abstract][Full Text] [Related]
15. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.
Borghi L; Meschi T; Guerra A; Bergamaschi E; Mutti A; Novarini A
Clin Chim Acta; 1995 Jul; 239(1):1-11. PubMed ID: 7586581
[TBL] [Abstract][Full Text] [Related]
16. The in-vivo effect of sodium-potassium citrate on the crystal growth rate of calcium oxalate and other parameters in human urine.
Achilles W; Schulze D; Schalk C; Rodeck G
Urol Res; 1990; 18(1):1-6. PubMed ID: 2316065
[TBL] [Abstract][Full Text] [Related]
17. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
18. Diurnal variation of urine composition in calcium oxalate stone disease during treatment with bendroflumethiazide.
Ahlstrand C; Tiselius HG; Larsson L
Eur Urol; 1984; 10(4):260-5. PubMed ID: 6541131
[TBL] [Abstract][Full Text] [Related]
19. The role of citrate complexes in preventing urolithiasis.
Ashby RA; Sleet RJ
Clin Chim Acta; 1992 Sep; 210(3):157-65. PubMed ID: 1468138
[TBL] [Abstract][Full Text] [Related]
20. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
Laube N; Jansen B; Hesse A
Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]